Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
56.58
+1.16 (2.08%)
Aug 12, 2026, 11:07 AM EDT - Market open
Ionis Pharmaceuticals Market Cap
Ionis Pharmaceuticals has a market cap or net worth of $9.4 billion as of August 12, 2026. Its market cap has increased by 44.43% in one year.
Market Cap
9.40B
Enterprise Value
9.49B
1-Year Change
44.43%
Ranking
Category
Stock Price
$56.58
ChartMarket Cap Chart
Since December 1, 1998, Ionis Pharmaceuticals's market cap has increased from $302.10M to $9.40B, an increase of 3,012.17%. That is a compound annual growth rate of 13.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 9.40B | -26.63% |
| Dec 31, 2025 | 12.81B | 132.13% |
| Dec 31, 2024 | 5.52B | -23.95% |
| Dec 29, 2023 | 7.26B | 35.28% |
| Dec 30, 2022 | 5.37B | 24.86% |
| Dec 31, 2021 | 4.30B | -45.65% |
| Dec 31, 2020 | 7.91B | -6.97% |
| Dec 31, 2019 | 8.50B | 14.26% |
| Dec 31, 2018 | 7.44B | 18.48% |
| Dec 29, 2017 | 6.28B | 8.28% |
| Dec 30, 2016 | 5.80B | -22.07% |
| Dec 31, 2015 | 7.44B | 1.99% |
| Dec 31, 2014 | 7.29B | 57.73% |
| Dec 31, 2013 | 4.62B | 337.67% |
| Dec 31, 2012 | 1.06B | 46.95% |
| Dec 30, 2011 | 719.00M | -28.40% |
| Dec 31, 2010 | 1.00B | -8.12% |
| Dec 31, 2009 | 1.09B | -20.54% |
| Dec 31, 2008 | 1.38B | 0.44% |
| Dec 31, 2007 | 1.37B | 62.24% |
| Dec 29, 2006 | 844.10M | 123.13% |
| Dec 30, 2005 | 378.30M | 11.96% |
| Dec 31, 2004 | 337.90M | -6.42% |
| Dec 31, 2003 | 361.10M | -0.61% |
| Dec 31, 2002 | 363.30M | -65.23% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 10.67B |
| Apogee Therapeutics | 10.12B |
| Praxis Precision Medicines | 10.07B |
| Krystal Biotech | 9.66B |
| Protagonist Therapeutics | 9.44B |
| Spyre Therapeutics | 9.25B |
| Kymera Therapeutics | 8.94B |
| Crinetics Pharmaceuticals | 8.92B |